A Review of Granulocyte Colony-stimulating Factor Receptor Signaling and Regulation with Implications for Cancer

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 29

PMID 36033452

Authors

Sungjin David Park

Apryl S Saunders

Megan A Reidy

Dawn E Bender

Shari Clifton

Katherine T Morris

Affiliations

Soon will be listed here.

Abstract

Granulocyte colony-stimulating factor receptor (GCSFR) is a critical regulator of granulopoiesis. Studies have shown significant upregulation of GCSFR in a variety of cancers and cell types and have recognized GCSFR as a cytokine receptor capable of influencing both myeloid and non-myeloid immune cells, supporting pro-tumoral actions. This systematic review aims to summarize the available literature examining the mechanisms that control GCSFR signaling, regulation, and surface expression with emphasis on how these mechanisms may be dysregulated in cancer. Experiments with different cancer cell lines from breast cancer, bladder cancer, glioma, and neuroblastoma are used to review the biological function and underlying mechanisms of increased GCSFR expression with emphasis on actions related to tumor proliferation, migration, and metastasis, primarily acting through the JAK/STAT pathway. Evidence is also presented that demonstrates a differential physiological response to aberrant GCSFR signal transduction in different organs. The lifecycle of the receptor is also reviewed to support future work defining how this signaling axis becomes dysregulated in malignancies.

Citing Articles

Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia.

Maffei R, Paolini A, Conte B, Riva G, Nasillo V, Creti F Ann Hematol. 2025; 104(1):263-274.

PMID: 39907800 PMC: 11868254. DOI: 10.1007/s00277-025-06232-1.

A strategy to design protein-based antagonists against type I cytokine receptors.

Ullrich T, Klimenkova O, Pollmann C, Lasram A, Hatskovska V, Maksymenko K PLoS Biol. 2024; 22(11):e3002883.

PMID: 39591631 PMC: 11596305. DOI: 10.1371/journal.pbio.3002883.

FRA1 controls acinar cell plasticity during murine Kras-induced pancreatic acinar to ductal metaplasia.

Li A, Sugiura K, Nishiwaki N, Suzuki K, Sadeghian D, Zhao J Dev Cell. 2024; 59(22):3025-3042.e7.

PMID: 39178842 PMC: 11576252. DOI: 10.1016/j.devcel.2024.07.021.

Interaction of the intestinal cytokines-JAKs-STAT3 and 5 axes with RNA N6-methyladenosine to promote chronic inflammation-induced colorectal cancer.

Esmaeili N, Bakheet A, Tse W, Liu S, Han X Front Oncol. 2024; 14:1352845.

PMID: 39136000 PMC: 11317299. DOI: 10.3389/fonc.2024.1352845.

SOX2-Dependent Wound Repair Signature Triggers Prohealing Outcome in Hyperglycemic Wounds.

ONeill C, Sawaya A, Mehdizadeh S, Brooks S, Hasneen K, Nayak S J Invest Dermatol. 2024; 145(2):451-455.e5.

PMID: 39127091 PMC: 11745936. DOI: 10.1016/j.jid.2024.07.012.

References

Chakraborty A, White S, Lerner S . Granulocyte colony-stimulating factor receptor signals for beta1-integrin expression and adhesion in bladder cancer. Urology. 2004; 63(1):177-83. DOI: 10.1016/s0090-4295(03)00786-6. View

Avalos B, Hunter M, Parker J, Ceselski S, Druker B, Corey S . Point mutations in the conserved box 1 region inactivate the human granulocyte colony-stimulating factor receptor for growth signal transduction and tyrosine phosphorylation of p75c-rel. Blood. 1995; 85(11):3117-26. View

Mao Y, Keller E, Garfield D, Shen K, Wang J . Stromal cells in tumor microenvironment and breast cancer. Cancer Metastasis Rev. 2012; 32(1-2):303-15. PMC: 4432936. DOI: 10.1007/s10555-012-9415-3. View

Beekman R, Valkhof M, Sanders M, van Strien P, Haanstra J, Broeders L . Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood. 2012; 119(22):5071-7. DOI: 10.1182/blood-2012-01-406116. View

Corey S, Burkhardt A, Bolen J, Geahlen R, Tkatch L, Tweardy D . Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A. 1994; 91(11):4683-7. PMC: 43852. DOI: 10.1073/pnas.91.11.4683. View

Gombart A, Grewal J, Koeffler H . ATF4 differentially regulates transcriptional activation of myeloid-specific genes by C/EBPepsilon and C/EBPalpha. J Leukoc Biol. 2007; 81(6):1535-47. DOI: 10.1189/jlb.0806516. View

Baffa R, Fassan M, Volinia S, OHara B, Liu C, Palazzo J . MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009; 219(2):214-21. DOI: 10.1002/path.2586. View

Morris K, Khan H, Ahmad A, Weston L, Nofchissey R, Pinchuk I . G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer. 2014; 110(5):1211-20. PMC: 3950854. DOI: 10.1038/bjc.2013.822. View

Luttman J, Colemon A, Mayro B, Pendergast A . Role of the ABL tyrosine kinases in the epithelial-mesenchymal transition and the metastatic cascade. Cell Commun Signal. 2021; 19(1):59. PMC: 8140471. DOI: 10.1186/s12964-021-00739-6. View

10.

Mehta H, Glaubach T, Long A, Lu H, Przychodzen B, Makishima H . Granulocyte colony-stimulating factor receptor T595I (T618I) mutation confers ligand independence and enhanced signaling. Leukemia. 2013; 27(12):2407-10. DOI: 10.1038/leu.2013.164. View

11.

Dong F, Pouwels K, Hoefsloot L, Rozemuller H, Lowenberg B, Touw I . The C-terminal cytoplasmic region of the granulocyte colony-stimulating factor receptor mediates apoptosis in maturation-incompetent murine myeloid cells. Exp Hematol. 1996; 24(2):214-20. View

12.

Recio C, Guerra B, Guerra-Rodriguez M, Aranda-Tavio H, Martin-Rodriguez P, de Mirecki-Garrido M . Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology. Oncogene. 2019; 38(24):4657-4668. DOI: 10.1038/s41388-019-0752-3. View

13.

Tian S, Tapley P, Sincich C, Stein R, Rosen J, Lamb P . Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood. 1996; 88(12):4435-44. View

14.

Yamanaka R, Kim G, Radomska H, Smith L, Antonson P, Tenen D . CCAAT/enhancer binding protein epsilon is preferentially up-regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc Natl Acad Sci U S A. 1997; 94(12):6462-7. PMC: 21072. DOI: 10.1073/pnas.94.12.6462. View

15.

Collins S, Ulmer J, Purton L, Darlington G . Multipotent hematopoietic cell lines derived from C/EBPalpha(-/-) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte- colony-stimulating factor, and retinoic acid-induced granulocytic differentiation. Blood. 2001; 98(8):2382-8. DOI: 10.1182/blood.v98.8.2382. View

16.

Touw I, van de Geijn G . Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders. Front Biosci. 2006; 12:800-15. DOI: 10.2741/2103. View

17.

Sloand E, Yong A, Ramkissoon S, Solomou E, Bruno T, Kim S . Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor. Proc Natl Acad Sci U S A. 2006; 103(39):14483-8. PMC: 1599987. DOI: 10.1073/pnas.0605245103. View

18.

Kirsch F, Kruger C, Schneider A . The receptor for granulocyte-colony stimulating factor (G-CSF) is expressed in radial glia during development of the nervous system. BMC Dev Biol. 2008; 8:32. PMC: 2329616. DOI: 10.1186/1471-213X-8-32. View

19.

Billia F, Barbara M, McEwen J, Trevisan M, Iscove N . Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. Blood. 2001; 97(8):2257-68. DOI: 10.1182/blood.v97.8.2257. View

20.

Dwivedi P, Greis K . Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies. Exp Hematol. 2016; 46:9-20. PMC: 5241233. DOI: 10.1016/j.exphem.2016.10.008. View